US OptionsDetailed Quotes
AMBA240802P50000
- 0.29
- -0.18-38.30%
15min DelayClose Jul 29 10:51 ET
0.29High0.29Low
0.29Open0.47Pre Close2 Volume9 Open Interest50.00Strike Price58.00Turnover59.62%IV5.82%PremiumAug 2, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.29Extrinsic Value100Contract SizeAmericanOptions Type-0.1916Delta0.0793Gamma140.75Leverage Ratio-0.1079Theta-0.0012Rho-26.97Eff Leverage0.0157Vega
Ambarella Stock Discussion
Sign in to post a comment
Stocks traded volatilely Friday as Wall Street marked May's final market day, but the main indexes ended the session higher as investors moved their focus off of tech and into other sectors.
The S&P 500 fell nearly 1% earlier the session due to a tech-sector selloff, but then rebounded -- ultimately allowing the index to end May with its best monthly gain since February.
The $S&P 500 Index(.SPX.US$ rose 0....
The S&P 500 fell nearly 1% earlier the session due to a tech-sector selloff, but then rebounded -- ultimately allowing the index to end May with its best monthly gain since February.
The $S&P 500 Index(.SPX.US$ rose 0....
45
2
Morning Movers
Gapping up
$Gap Inc(GPS.US$ stock surged 23% as the clothing retailer increased its full-year sales outlook, signaling that its turnaround efforts may be gaining traction.
$Zscaler(ZS.US$ stock climbed 15% following the cloud security company's report of robust quarterly earnings and an upward revision of its guidance.
$Ambarella(AMBA.US$ stock soared 20% after the chip designer posted a smaller-than-expected ...
Gapping up
$Gap Inc(GPS.US$ stock surged 23% as the clothing retailer increased its full-year sales outlook, signaling that its turnaround efforts may be gaining traction.
$Zscaler(ZS.US$ stock climbed 15% following the cloud security company's report of robust quarterly earnings and an upward revision of its guidance.
$Ambarella(AMBA.US$ stock soared 20% after the chip designer posted a smaller-than-expected ...
30
Insiders at Ambarella selling shares without any recorded purchases raises caution. The lack of buying activity over the last twelve months does not instill confidence in the company's prospects.
1
The uninspiring revenue growth and lack of profitability have likely led to the share price decline. However, if data indicates long term growth, the current sell-off could be an opportunity. Investors should be aware of 3 warning signs.
1
Morning Movers
Gapping up
$Tesla(TSLA.US$ stock rose 0.3% after Chief Executive Elon Musk said the electric vehicle manufacturer had completed production design on a long-planned update to its Roadster electric sportscar, adding that it was likely to ship starting next year.
$TJX Companies(TJX.US$ stock rose 1.4% after the retailer topped market expectations for fourth-quarter sales on Wednesday as shoppers flocked to its T...
Gapping up
$Tesla(TSLA.US$ stock rose 0.3% after Chief Executive Elon Musk said the electric vehicle manufacturer had completed production design on a long-planned update to its Roadster electric sportscar, adding that it was likely to ship starting next year.
$TJX Companies(TJX.US$ stock rose 1.4% after the retailer topped market expectations for fourth-quarter sales on Wednesday as shoppers flocked to its T...
28
Ambarella's current undervaluation is a good opportunity for investors. Its positive growth outlook isn't fully reflected in the share price. Other factors like capital structure should be considered. Now might be a good time to invest, given its prosperous future outlook and current undervaluation.
Ambarella insiders' exclusive sales hint that they may find the stock overvalued. Despite this, their 5.9% company ownership indicates a significant alignment with the interest of overall shareholders. Unfortunately, little insider buying over the last year doesn't assure confidence in the firm’s future.
Despite Ambarella's undervaluation, the article highlights the risks associated with its negative growth outlook. It suggests this could be a decision-making moment for investors, but warns of underlying dangers.
Analysts suggest the 9% share price growth may not entirely reflect the company's growth, emphasizing revenue and its increase, despite last year's losses. Market's positive long term view, despite recent share price drop, makes it worth tracking.
$Apartment Income(AIRC.US$ $Allarity Therapeutics(ALLR.US$ $Ambarella(AMBA.US$ $Axcella Health(AXLA.US$ $Biomarin Pharmaceutical(BMRN.US$ $Salesforce(CRM.US$ $CrowdStrike(CRWD.US$ $FibroGen(FGEN.US$ $Infobird Software(IFBD.US$ $Lifevantage(LFVN.US$ $NanoVibronix(NAOV.US$ $Norfolk Southern(NSC.US$ $Okta(OKTA.US$ $TG Therapeutics(TGTX.US$ $The Trade Desk(TTD.US$ $Beyond Air(XAIR.US$
1
No comment yet
102188459 : Good
151873257 : Healthy that the Spyders and DIA recovered. Good news.